● Recruiting

A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)

Condition: Chronic Hepatitis B Infection · Sponsor: Aligos Therapeutics

PhasePhase 2

Planned participants200

Who can joinAll sexes, 18 Years to 65 Years

Healthy volunteersNo

About this study

This is a Phase 2 study to evaluate efficacy and safety of 48 weeks of oral once daily monotherapy with ALG-000184 versus tenofovir disproxil fumarate (TDF) for chronic HBV infection.

This description comes directly from the study's public registry record.

Talk to the study team

Aligos Therapeutics · (800) 466-6059 · info@aligos.com

Always discuss trial participation with your own doctor first.

Locations (58)

Aligos Investigational Site	Chandler, Arizona, United States	Recruiting
Aligos Investigational Site	Coronado, California, United States	Recruiting
Aligos Investigational Site	Garden Grove, California, United States	Recruiting
Aligos Investigational Site	Los Angeles, California, United States	Recruiting
Aligos Investigational Site	Palo Alto, California, United States	Recruiting
Aligos Investigational Site	Pasadena, California, United States	Recruiting
Aligos Investigational Site	Rialto, California, United States	Recruiting
Aligos Investigational Site	San Francisco, California, United States	Recruiting
Aligos Investigational Site	San Jose, California, United States	Recruiting
Aligos Investigational Site	Miami, Florida, United States	Recruiting
Aligos Investigational Site	Miami, Florida, United States	Recruiting
Aligos Investigational Site	Marrero, Louisiana, United States	Recruiting

+ 46 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06963710